Agatolimod sodiumProduct ingredient for Agatolimod

Show full entry for Agatolimod
Name
Agatolimod sodium
Drug Entry
Agatolimod

Agatolimod is under investigation in clinical trial NCT00471471 (Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery).

See full entry for Agatolimod
Accession Number
DBSALT003334
Structure
Synonyms
Not Available
External IDs
CPG 7909 / CPG-7909 / PF-03512676 / PF-3512676
UNII
I4Z5C8FM6H
CAS Number
541547-35-7
Not Available
Predicted Properties
Not Available